Dusko Ivanovic’s team fights to the end, but cannot achieve their thirteenth victory in the Euroleague
Gasteiz’s team lost to Bayern Munich in a match in which nothing was decided until the end. Cody Miller-McIntyre’s 3-pointer forced overtime, but they couldn’t win. The American point guard was the best of the match and exceeded his best in the tournament with 20 points, 15 assists and 39 rating points.
An exchange of blows at the beginning of the fight in Munich. The Blaugrana took the reins and took the lead on the scoreboard. Pablo Lazo’s team didn’t have to wait long and took the lead (25-19) at the end of the first quarter. The local team’s success in front of the basket allowed them to increase their lead over the Basconists and forced the Montenegrin coach to stop the match. Baskonia responded and went into the break with a four-point lead (56-52).
At the restart, the fit Markus Howard from the line 6.75 (threes 6/7) took control of the match and reduced the gap on the scoreboard. The Basconistas tried to take the lead, but Bayern’s good performance in the final seconds of the quarter kept them in the lead (82-76). Baskonia did not give up and came out ready for anything. Cody Miller-McIntyre hit a triple with 3 seconds left to force overtime in Munich. The Basque team lost to Pablo Lazo’s team with a score of 112:109.
Dusko Ivanovic’s team is looking forward to the next matches this week. Maccabi Tel Aviv visits Buesa Arena in their next European match (Thursday, 20:30). On Sunday, the Blaugrana travel to Tenerife to face Lenovo in a new round of domestic competition (13:00).
He Euribor is collapsing. On November 15 this year it will fall to 2.475% for…
Subscribe to National Geographic for just 1 euro per month for 6 months. For a…
While we should not ignore the geopolitical context that led to this match, nor the…
CRITICIZE - A couple of years later, Michel Franco's film explores memory lapses. The story…
Maori representatives have suspended session in the New Zealand Parliament this Thursday. And they have…
The decision limits Lakembi's use to treat Alzheimer's disease to patients who have one copy…